Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3467)
MapLight Therapeutics, Inc. (MLPT)
Lillie James Woodruff — Chief Scientific Officer
Shares
2,238
Price
$36.00
Total Value
$80.57K
Shares Held After
240,491
% of Holdings
0.9%
MapLight Therapeutics, Inc. (MLPT)
Foff Erin Pennock — Chief Medical Officer
Shares
18
Price
$37.54
Total Value
$675.72
Shares Held After
317,604
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MLPT)
Foff Erin Pennock — Chief Medical Officer
Shares
8,972
Price
$36.99
Total Value
$331.87K
Shares Held After
317,622
% of Holdings
2.7%
MapLight Therapeutics, Inc. (MLPT)
Foff Erin Pennock — Chief Medical Officer
Shares
4,465
Price
$36.00
Total Value
$160.74K
Shares Held After
326,594
% of Holdings
1.3%
MapLight Therapeutics, Inc. (MLPT)
Foff Erin Pennock — Chief Medical Officer
Shares
7,845
Price
$37.04
Total Value
$290.58K
Shares Held After
331,059
% of Holdings
2.3%
MapLight Therapeutics, Inc. (MLPT)
Foff Erin Pennock — Chief Medical Officer
Shares
7,155
Price
$36.16
Total Value
$258.72K
Shares Held After
338,904
% of Holdings
2.1%
MapLight Therapeutics, Inc. (MLPT)
Hanson Kristopher — General Counsel
Shares
10
Price
$37.54
Total Value
$375.40
Shares Held After
155,071
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MLPT)
Hanson Kristopher — General Counsel
Shares
5,103
Price
$36.99
Total Value
$188.76K
Shares Held After
155,081
% of Holdings
3.2%
MapLight Therapeutics, Inc. (MLPT)
Hanson Kristopher — General Counsel
Shares
2,147
Price
$36.00
Total Value
$77.29K
Shares Held After
160,184
% of Holdings
1.3%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
105,762
Price
$22.59
Total Value
$2.39M
Shares Held After
230,713
% of Holdings
31.4%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
1,000
Price
$1.55
Total Value
$1.55K
Shares Held After
801,000
% of Holdings
0.1%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
4,000
Price
$33.99
Total Value
$135.97K
Shares Held After
174,209
% of Holdings
2.2%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
1,978
Price
$89.49
Total Value
$177.01K
Shares Held After
1,084,543
% of Holdings
0.2%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
2,974
Price
$88.81
Total Value
$264.12K
Shares Held After
1,086,521
% of Holdings
0.3%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
3,969
Price
$87.74
Total Value
$348.22K
Shares Held After
1,089,495
% of Holdings
0.4%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
1,079
Price
$86.78
Total Value
$93.63K
Shares Held After
1,093,464
% of Holdings
0.1%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
101
Price
$89.43
Total Value
$9.03K
Shares Held After
16,130
% of Holdings
0.6%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
3,520
Price
$88.30
Total Value
$310.82K
Shares Held After
16,231
% of Holdings
17.8%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
28,460
Price
$87.89
Total Value
$2.50M
Shares Held After
19,751
% of Holdings
59.0%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
7,919
Price
$86.78
Total Value
$687.18K
Shares Held After
48,211
% of Holdings
14.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
7,640
Price
$313.58
Total Value
$2.40M
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
48,657
Price
$312.86
Total Value
$15.22M
Shares Held After
7,640
% of Holdings
86.4%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
12,857
Price
$311.71
Total Value
$4.01M
Shares Held After
56,297
% of Holdings
18.6%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
41,336
Price
$310.92
Total Value
$12.85M
Shares Held After
69,154
% of Holdings
37.4%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
6,067
Price
$310.02
Total Value
$1.88M
Shares Held After
110,490
% of Holdings
5.2%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
41,668
Price
$5.06
Total Value
$210.92K
Shares Held After
1,678,366
% of Holdings
2.4%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$10.61
Total Value
$10.61K
Shares Held After
18,592
% of Holdings
5.4%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
1,000
Price
$71.17
Total Value
$71.17K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,911
Price
$150.25
Total Value
$287.13K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,029
Price
$149.27
Total Value
$153.60K
Shares Held After
1,911
% of Holdings
35.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
840
Price
$148.40
Total Value
$124.66K
Shares Held After
2,940
% of Holdings
22.2%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
522
Price
$147.14
Total Value
$76.81K
Shares Held After
3,780
% of Holdings
12.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
4,730
Price
$26.91
Total Value
$127.28K
Shares Held After
37,109
% of Holdings
11.3%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
1,389
Price
$1.55
Total Value
$2.15K
Shares Held After
75,017
% of Holdings
1.9%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
13,761
Price
$1.55
Total Value
$21.33K
Shares Held After
743,038
% of Holdings
1.9%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
1,600
Price
$2.44
Total Value
$3.90K
Shares Held After
2,835,581
% of Holdings
0.1%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
53,336
Price
$67.60
Total Value
$3.61M
Shares Held After
1,483,848
% of Holdings
3.5%
Monte Rosa Therapeutics, Inc. (GLUE)
Champoux Jennifer — Chief Operating Officer
Shares
4,351
Price
$23.38
Total Value
$101.73K
Shares Held After
62,371
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$534.27
Total Value
$64.11K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
825
Price
$533.08
Total Value
$439.79K
Shares Held After
324,563
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,295
Price
$531.97
Total Value
$1.75M
Shares Held After
325,388
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,044
Price
$531.03
Total Value
$554.39K
Shares Held After
328,683
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
577
Price
$530.12
Total Value
$305.88K
Shares Held After
329,727
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
641
Price
$529.03
Total Value
$339.11K
Shares Held After
330,304
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$527.77
Total Value
$63.33K
Shares Held After
330,945
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$525.24
Total Value
$147.07K
Shares Held After
331,065
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$524.40
Total Value
$230.73K
Shares Held After
331,345
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
203
Price
$523.20
Total Value
$106.21K
Shares Held After
331,785
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
189
Price
$521.84
Total Value
$98.63K
Shares Held After
331,988
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
48
Price
$520.92
Total Value
$25.00K
Shares Held After
332,177
% of Holdings
0.0%
Showing 401–450 of 3467 transactions (page 9 of 70)